Event Scheduled for December 8, 2025 at 12:30 PM ETSAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc....
FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary...
FREDERICK, Md., Dec. 2, 2025 /PRNewswire/ -- The "Where Energy Meets Matter" exhibition will run through January 20, 2026, at...
Following a $298M Series B, Function is accelerating technology and product leadership to expand AI capabilities and its Medical Intelligence...
FORT MYERS, Fla., Dec. 2, 2025 /PRNewswire/ -- Bridge To A Cure Foundation announces the appointment of Winston Ely to its...
ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on...
US Med-Equip Elves Helping Non-Profit Supporting Hospitalized Children with Cancer HOUSTON, TX / ACCESS Newswire / December 2, 2025 /...
Recognized leader in pathology joins mission to begin clinically offering eLIVE™ to oncologists and pathologistsMADISON, Wis., Dec. 2, 2025 /PRNewswire/...
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modelingSEOUL, South Korea, Dec. 2,...
First-of-its-kind partnership between Aidoc and NVIDIA MONAI takes models from lab to scaled clinical use; new Quibim collaboration adds best-in-class Prostate...
IRVING, Texas, Dec. 2, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision...
Vincent Reid, MD, FACS, Chairman of Surgery and Medical Director at the Hall Perrine Cancer Center, Mercy Cedar Rapids, to...
BOSTON, Dec. 2, 2025 /PRNewswire/ -- Clairity, developer of the first image-only AI model authorized by the U.S. Food and...
Los Angeles, California--(Newsfile Corp. - December 2, 2025) - This Giving Tuesday the St. Baldrick's Foundation, the largest charity funder...
MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BetaGlue® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing...
- FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent...
Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia®A novel non-antibiotic approach...
– Eflornithine and lomustine combination doubled progression free survival (PFS) and improved overall survival (OS) in patients with recurrent Grade...
Taipei, Taiwan, Dec. 02, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology...
Appointment reinforces clinical and translational depth as Ernexa advances its best-in-class iMSC cell therapy platform into first-in-human trialsCAMBRIDGE, Mass., Dec....